Title: International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors.
Journal: Pharmacological reviews 20150701
Title: Phase 2a, randomized, double-blind, placebo-controlled, multicenter, parallel-group study of a H4 R-antagonist (JNJ-39758979) in Japanese adults with moderate atopic dermatitis.
Journal: The Journal of dermatology 20150201
Title: The histamine H₄ receptor antagonist, JNJ 39758979, is effective in reducing histamine-induced pruritus in a randomized clinical study in healthy subjects.
Journal: The Journal of pharmacology and experimental therapeutics 20140701
Title: Clinical and preclinical characterization of the histamine H(4) receptor antagonist JNJ-39758979.
Journal: The Journal of pharmacology and experimental therapeutics 20140501
Title: Discovery and SAR of 6-alkyl-2,4-diaminopyrimidines as histamine H₄ receptor antagonists.
Journal: Journal of medicinal chemistry 20140327
Title: Savall BM, et al. Discovery and SAR of 6-alkyl-2,4-diaminopyrimidines as histamine H4 receptor antagonists. J Med Chem. 2014 Mar 27;57(6):2429-39.
Title: Murata Y, et al. Phase 2a, randomized, double-blind, placebo-controlled, multicenter, parallel-group study of a H4 R-antagonist (JNJ-39758979) in Japanese adults with moderate atopic dermatitis.